AU3952593A - Amides having inhibiting activity on phospholipase A2, a process for the preparation thereof and pharmaceutical compositions containing them - Google Patents

Amides having inhibiting activity on phospholipase A2, a process for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
AU3952593A
AU3952593A AU39525/93A AU3952593A AU3952593A AU 3952593 A AU3952593 A AU 3952593A AU 39525/93 A AU39525/93 A AU 39525/93A AU 3952593 A AU3952593 A AU 3952593A AU 3952593 A AU3952593 A AU 3952593A
Authority
AU
Australia
Prior art keywords
phospholipase
amides
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39525/93A
Inventor
Germano Carganico
Maria Luisa Garcia Perez
David Mauleon Casellas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Publication of AU3952593A publication Critical patent/AU3952593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU39525/93A 1992-04-14 1993-04-07 Amides having inhibiting activity on phospholipase A2, a process for the preparation thereof and pharmaceutical compositions containing them Abandoned AU3952593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09200809A ES2044781B1 (en) 1992-04-14 1992-04-14 PROCEDURE FOR THE PREPARATION OF NEW AMIDES WITH PHOSPHOLIPASE A2 INHIBITING ACTION
ES9200809 1992-04-14

Publications (1)

Publication Number Publication Date
AU3952593A true AU3952593A (en) 1993-11-18

Family

ID=8276745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39525/93A Abandoned AU3952593A (en) 1992-04-14 1993-04-07 Amides having inhibiting activity on phospholipase A2, a process for the preparation thereof and pharmaceutical compositions containing them

Country Status (3)

Country Link
AU (1) AU3952593A (en)
ES (1) ES2044781B1 (en)
WO (1) WO1993021211A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU708306B2 (en) * 1995-07-24 1999-07-29 Fujisawa Pharmaceutical Co., Ltd. Esters and amides as PLA2 inhibitors
CA2227466A1 (en) * 1995-07-24 1997-02-06 Fujisawa Pharmaceutical Co., Ltd. Esters and amides as pla2 inhibitors
US7893226B2 (en) 2004-09-29 2011-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US9040078B2 (en) 2000-01-10 2015-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases of the nervous system
US7608598B2 (en) 2000-01-10 2009-10-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of conjunctivitis
US8916539B2 (en) 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US7772196B2 (en) 2000-01-10 2010-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US8883761B2 (en) 2001-01-10 2014-11-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases associated with vasculature
ATE343375T1 (en) 2001-03-27 2006-11-15 Biomira Inc VACCINE FOR MODULATION BETWEEN T1 AND T2 IMMUNE RESPONSES
US20060069238A1 (en) * 2002-04-15 2006-03-30 Biomira, Inc. Synthetic glyco-lipo-peptides as vaccines
TW201204410A (en) 2004-04-01 2012-02-01 Oncothyreon Inc Mucinous glycoprotein (MUC-1) vaccine
EA012138B1 (en) * 2004-11-17 2009-08-28 Йиссум Рисерч Дивелопмент Компани Оф Дзе Хебрю Юниверсити Оф Иерусалим Use of lipid conjugates in the treatment of diseases
DK2366400T3 (en) 2005-06-28 2016-01-11 Oncothyreon Inc A method for the treatment of patients with mucinous glycoprotein (MUC-1) vaccine
WO2012116225A2 (en) 2011-02-24 2012-08-30 Oncothyreon Inc. Muc1 based glycolipopeptide vaccine with adjuvant
CN105152986B (en) * 2015-09-09 2017-08-25 武汉华纳联合药业有限公司 Cysteine Homotaurine dipeptides and its derivative and its medical usage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1964798A1 (en) * 1969-01-07 1970-07-16 Ciba Geigy New pharmaceutical preparations
NL175293C (en) * 1972-02-08 1984-10-16 Akzo Nv METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH A PSYCHOPHARMACOLOGICAL ACTION, AND A METHOD FOR PREPARING A VASOPRESSIN DERIVED PEPTIDE.
US4111924A (en) * 1976-01-05 1978-09-05 Takeda Chemical Industries, Ltd. Method for removal of thiol-protecting groups
IL84252A (en) * 1987-10-23 1994-02-27 Yissum Res Dev Co Phospholipase inhibiting compositions

Also Published As

Publication number Publication date
ES2044781A1 (en) 1994-01-01
WO1993021211A1 (en) 1993-10-28
ES2044781B1 (en) 1994-10-01

Similar Documents

Publication Publication Date Title
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU3173095A (en) Novel pharmaceutical product
AU5681294A (en) Tastemasked pharmaceutical materials
GB2220206B (en) Carboxamide compounds,processes for preparing the same and a pharmaceutical composition containing the same
IL106600A0 (en) Peptides,pharmaceutical compositions containing the same and processes for the preparation thereof
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU3952593A (en) Amides having inhibiting activity on phospholipase A2, a process for the preparation thereof and pharmaceutical compositions containing them
AU4642393A (en) Medication sprayer
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU3542993A (en) Pharmaceutical compounds
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
GB2283171B (en) Pharmaceutical products
AU3876293A (en) New heterocyclic compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
IL117629A0 (en) Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof
AU3949093A (en) A pharmaceutical formulation
AU6190594A (en) New substituted benzodioxins, a process for their preparation and pharmaceutical compositions containing them
AU3659693A (en) Multiple package for pharmaceutical products
AU3010589A (en) Trisubstituted amines, processes for the preparation thereof and pharmaceutical compositions containing them
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
ZA9610002B (en) New compounds pharmaceutical preparations containing them and a process for the preparation thereof
ZA935862B (en) New hydrazono-5Béta 14Béta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
AU3101593A (en) New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it